Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)

G. Montalban-Bravo; X. Huang; K. Naqvi; E. Jabbour; G. Borthakur; C. D. DiNardo; N. Pemmaraju; J. Cortes; S. Verstovsek; T. Kadia; N. Daver; W. Wierda; Y. Alvarado; M. Konopleva; F. Ravandi; Z. Estrov; N. Jain; A. Alfonso; M. Brandt; T. Sneed; H. C. Chen; H. Yang; C. Bueso-Ramos; S. Pierce; E. Estey; Z. Bohannan; H. M. Kantarjian; G. Garcia-Manero

doi:10.1038/leu.2017.85

Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)

G. Montalban-Bravo, X. Huang, K. Naqvi, E. Jabbour, G. Borthakur, C. D. DiNardo, N. Pemmaraju, J. Cortes, S. Verstovsek, T. Kadia, N. Daver, W. Wierda, Y. Alvarado, M. Konopleva, F. Ravandi, Z. Estrov, N. Jain, A. Alfonso, M. Brandt, T. SneedH. C. Chen, H. Yang, C. Bueso-Ramos, S. Pierce, E. Estey, Z. Bohannan, H. M. Kantarjian, G. Garcia-Manero

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

Correction to: Leukemia (2017) 31, 318–324; doi:10.1038/leu.2016.303; published online 18 November 2016 Following the publication of this article, the authors noted that Dr Naqvi’s name should have been included. The complete and correct author names appear above. Dr Naqvi’s affiliation is Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Original language	English (US)
Pages (from-to)	1659
Number of pages	1
Journal	Leukemia
Volume	31
Issue number	7
DOIs	https://doi.org/10.1038/leu.2017.85
State	Published - Jul 2017
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2017.85

Cite this

Montalban-Bravo, G., Huang, X., Naqvi, K., Jabbour, E., Borthakur, G., DiNardo, C. D., Pemmaraju, N., Cortes, J., Verstovsek, S., Kadia, T., Daver, N., Wierda, W., Alvarado, Y., Konopleva, M., Ravandi, F., Estrov, Z., Jain, N., Alfonso, A., Brandt, M., ... Garcia-Manero, G. (2017). Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303). Leukemia, 31(7), 1659. https://doi.org/10.1038/leu.2017.85

Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303). / Montalban-Bravo, G.; Huang, X.; Naqvi, K. et al.
In: Leukemia, Vol. 31, No. 7, 07.2017, p. 1659.

Research output: Contribution to journal › Comment/debate › peer-review

Montalban-Bravo, G, Huang, X, Naqvi, K, Jabbour, E, Borthakur, G, DiNardo, CD, Pemmaraju, N, Cortes, J, Verstovsek, S, Kadia, T, Daver, N, Wierda, W, Alvarado, Y, Konopleva, M, Ravandi, F, Estrov, Z, Jain, N, Alfonso, A, Brandt, M, Sneed, T, Chen, HC, Yang, H, Bueso-Ramos, C, Pierce, S, Estey, E, Bohannan, Z, Kantarjian, HM & Garcia-Manero, G 2017, 'Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)', Leukemia, vol. 31, no. 7, pp. 1659. https://doi.org/10.1038/leu.2017.85

@article{324c8aefbada42d8b43cfefbc68cd2c6,

title = "Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)",

abstract = "Correction to: Leukemia (2017) 31, 318–324; doi:10.1038/leu.2016.303; published online 18 November 2016 Following the publication of this article, the authors noted that Dr Naqvi{\textquoteright}s name should have been included. The complete and correct author names appear above. Dr Naqvi{\textquoteright}s affiliation is Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.",

author = "G. Montalban-Bravo and X. Huang and K. Naqvi and E. Jabbour and G. Borthakur and DiNardo, {C. D.} and N. Pemmaraju and J. Cortes and S. Verstovsek and T. Kadia and N. Daver and W. Wierda and Y. Alvarado and M. Konopleva and F. Ravandi and Z. Estrov and N. Jain and A. Alfonso and M. Brandt and T. Sneed and Chen, {H. C.} and H. Yang and C. Bueso-Ramos and S. Pierce and E. Estey and Z. Bohannan and Kantarjian, {H. M.} and G. Garcia-Manero",

note = "Publisher Copyright: {\textcopyright} 2017, Macmillan Publishers Limited, part of Springer Nature.",

year = "2017",

month = jul,

doi = "10.1038/leu.2017.85",

language = "English (US)",

volume = "31",

pages = "1659",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)

AU - Montalban-Bravo, G.

AU - Huang, X.

AU - Naqvi, K.

AU - Jabbour, E.

AU - Borthakur, G.

AU - DiNardo, C. D.

AU - Pemmaraju, N.

AU - Cortes, J.

AU - Verstovsek, S.

AU - Kadia, T.

AU - Daver, N.

AU - Wierda, W.

AU - Alvarado, Y.

AU - Konopleva, M.

AU - Ravandi, F.

AU - Estrov, Z.

AU - Jain, N.

AU - Alfonso, A.

AU - Brandt, M.

AU - Sneed, T.

AU - Chen, H. C.

AU - Yang, H.

AU - Bueso-Ramos, C.

AU - Pierce, S.

AU - Estey, E.

AU - Bohannan, Z.

AU - Kantarjian, H. M.

AU - Garcia-Manero, G.

PY - 2017/7

Y1 - 2017/7

N2 - Correction to: Leukemia (2017) 31, 318–324; doi:10.1038/leu.2016.303; published online 18 November 2016 Following the publication of this article, the authors noted that Dr Naqvi’s name should have been included. The complete and correct author names appear above. Dr Naqvi’s affiliation is Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

AB - Correction to: Leukemia (2017) 31, 318–324; doi:10.1038/leu.2016.303; published online 18 November 2016 Following the publication of this article, the authors noted that Dr Naqvi’s name should have been included. The complete and correct author names appear above. Dr Naqvi’s affiliation is Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

UR - http://www.scopus.com/inward/record.url?scp=85076359036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076359036&partnerID=8YFLogxK

U2 - 10.1038/leu.2017.85

DO - 10.1038/leu.2017.85

M3 - Comment/debate

C2 - 28338082

AN - SCOPUS:85076359036

SN - 0887-6924

VL - 31

SP - 1659

JO - Leukemia

JF - Leukemia

IS - 7

ER -

Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this